Baker Avenue Asset Management’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1,141
Closed -$215K 860
2026
Q1
$215K Sell
1,141
-40
-3% -$8.43K ﹤0.01% 709
2025
Q4
$235K Sell
1,181
-24
-2% -$4.85K 0.01% 574
2025
Q3
$245K Buy
+1,205
New +$214K 0.01% 529
2023
Q4
Sell
-197
Closed -$13K 1376
2023
Q3
$13K Hold
197
﹤0.01% 725
2023
Q2
$16K Hold
197
﹤0.01% 680
2023
Q1
$11.7K Hold
197
﹤0.01% 742
2022
Q4
$9.61K Buy
+197
New +$9.11K ﹤0.01% 713
2022
Q3
Sell
-80,578
Closed -$4.24M 374
2022
Q2
$4.24M Buy
80,578
+677
+0.8% +$47.1K 0.28% 80
2022
Q1
$6.87M Buy
79,901
+565
+0.7% +$46.4K 0.35% 78
2021
Q4
$6.48M Buy
79,336
+4,100
+5% +$300K 0.32% 77
2021
Q3
$5M Sell
75,236
-18,812
-20% -$1.33M 0.29% 80
2021
Q2
$6.3M Buy
94,048
+2,398
+3% +$149K 0.36% 70
2021
Q1
$4.76M Sell
91,650
-30,934
-25% -$1.56M 0.29% 73
2020
Q4
$4.89M Sell
122,584
-368
-0.3% -$11.9K 0.33% 66
2020
Q3
$3.01M Buy
+122,952
New +$3.14M 0.23% 70

Other funds holding THC

Baker Avenue Asset Management's THC Position: Q2 2026 in Review

Baker Avenue Asset Management sold out of Tenet Healthcare (THC) in Q2 2026, closing a stake of 1,141 shares — an estimated $215K sold.

Baker Avenue Asset Management first reported a position in THC in Q3 2020 and held it in 15 quarters. The position peaked at $6.87M in Q1 2022. 673 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • Baker Avenue Asset Management reported no remaining Tenet Healthcare position as of Q2 2026 after selling out during the quarter.
  • Baker Avenue Asset Management sold 1,141 Tenet Healthcare shares in Q2 2026, an estimated $215K.
  • Baker Avenue Asset Management first reported a position in Tenet Healthcare in Q3 2020 and held it in 15 quarters.
  • Baker Avenue Asset Management's Tenet Healthcare position peaked at $6.87M in Q1 2022.
  • 673 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on Baker Avenue Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.